chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore arm fatigue numbness in face, under eye and check couldn't feel temperature on the left side of her mouth hip pain
husband reports pt was hospitalized 5 days after vaccine and multiple hospital visits thereafter; stated problems keeping blood pressure under control, reports high blood pressure developed 5 days after shot
Patient reported unresolved itching and swelling at injection site that started within 2 days of receiving the vaccine.
Dilation swelling in throat minutes after vaccination. Also became nauseated and light headed minutes afterward. Had to lie down at home. About 2 to 3 hours later. Right side of face flushed/light rash and right eye drooped and almost closed. Stayed this way for about 3 hours before eye started to resume to normal. Didn't affect left side of body.
Patient called the pharmacy reported that she has a red ring around her upper arm and it's swelling. She thinks it's the Pneumovax that she's allergic to.
Initial report was received from a consumer on 11 September 2014. A 72 year-old female with a history of MS had received on an unspecified date in August 2014 a "flu shot" (manufacturer, lot number, route and site of administration not reported) and an unspecified amount of time later had vomiting, diarrhea, became dehydrated and passed out at their HCP office. The patient went to the hospital where she received fluids and was sent home after about five hours. Concomitant medications included AUBAGIO, 14 mg daily orally starting 10 September 2013 for MS. No further information was provided at the time of this report. Outcome was recovered. Documents held by sender: none.
Severe chilling, violent shivering that lasted, non-stop, for about 90 minutes, beginning about 9:30 p.m. on the evening of having received injection.  Only other symptoms were moderate headache and upset stomach.
Hive rash over body, 3 days, post vax, treated with Benadryl.
Mild case of Bell's Palsy in which the left side of my face became numb and muscles were unable to move. Was treated with steroids and most function came back within 7 days.
Feel cold; This spontaneous case was reported by a consumer and describes the occurrence of FEELING COLD (Feel cold) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Sulfa Allergy). Concomitant products included VITAMIN C [ASCORBIC ACID], VITAMIN D NOS, CLONAZEPAM and SIMVASTATIN (ZOCOR) for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Mar-2021, the patient experienced FEELING COLD (Feel cold). At the time of the report, FEELING COLD (Feel cold) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medications were not provided.
pt recvd vax 9FEB95 & 17FEB95 c/o h/a, nausea & malaise; onset of sx began in the evening of 14FEB95 (5 days post 2nd vax); recommended bedrest APAP & fluids;
Patient c/o tingling to scalp and right arm , reports same type of reaction to certain plants or environmental allergies. Patient requested Benadryl, denies any itching, sob, swelling or hives. VS- 154/83, 62, 97%, 18.  Patient given PO Benadryl 25 mg and monitored x 30 minutes, reports symptoms improved and without any new symptoms, spouse driving her home
had the flu symptoms for 48 hrs in bed; migraines; high fever; Chills; vomiting; Initial information received on 01-Dec-2020 regarding an unsolicited valid non-serious case from a non-health care professional via social media.  This case involves an adult female patient with an unknown age who had the flu symptoms for 48 hours in bed (influenza), high fever (pyrexia), chills, vomiting, migraine, while being received vaccine influenza vaccine.  The patient's medical history, past medical treatment, vaccination, family history and concomitant medication were not reported.  On an unknown date, the patient received a dose of suspect influenza vaccine (produced by unknown manufacturer) (batch number and other dosing details were not reported) for prophylactic vaccination.  On an unknown date, (latency: unknown) after starting the suspect vaccine therapy, the patient had high fever (pyrexia), chills, vomiting, migraines, never had the flu but had the flu symptoms for 48 hours in bed (influenza).  No laboratory data was reported.  It was not reported if the patient received any corrective treatment. At the time of reporting, outcome of the event was unknown.  There will be no information available regarding batch number in this case. No further relevant information was reported.
GB syndrome; This case was reported by a consumer via interactive digital media and described the occurrence of guillain barre syndrome in a female patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced guillain barre syndrome (serious criteria GSK medically significant). On an unknown date, the outcome of the guillain barre syndrome was unknown.   The reporter considered the guillain barre syndrome to be related to Shingles vaccine.  Additional details were provided as follows: The case was reported by patient's friend. The age at vaccination was not reported. The patient had shingles shot which caused her to suffer the Guillain Barre syndrome. Follow-up would not be possible as no contact details available.
This spontaneous report was received from a nurse practitioner referring to an unknown number of patients of unknown ages and genders. The patients' medical histories and concurrent conditions were not provided. On unknown dates, the patients were vaccinated with improperly stored dose of GARDASIL 9 (indication, dose, frequency and dose number were not provided) (Lot # K026246 with an expiration date in 28-JAN-2017). No adverse effects were reported. The vaccines were exposed to a temperature excursion of 15.6 Celsius degrees for 1 hour and 59 minutes. Concomitant medication information was not provided. This is one of two reports from the same reporter. Additional information is not expected as no consent for follow up was provided.
06/21/2021: Pt reports to ED with left leg pain and swelling that has been intermittent for 1 month Duplex ultrasound - Acute deep vein thrombosis in the external iliac, common femoral, profunda, femoral, popliteal, posterior tibial and peroneal veins of the left lower extremity. 6/22/21: mechanical thrombectomy and stent placement. pt started on plavix, asa and xarelto - follow  up in 3 weeks 7/29/21 (CTA 10/7/2020 after bicycle accident: revealed significant extrinsic compression of the left common  iliac vein by the overlying right common iliac artery).
Information was received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received concerning the patient's past medical history, concurrent conditions, or concomitant medication. During 2012, the patient was inoculated with ZOSTAVAX (lot number, dosage, and route of administration not provided), at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The ZOSTAVAX vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 04-JUN-2016, the patient was treated at a healthcare facility/office (by an unspecified healthcare professional) for the onset of a severe vesicular rash, which was diagnosed as shingles. On or about 26-JUL-2016, the patient sought subsequent treatment at the healthcare facility/office, for continued and worsening vesicular outbreaks, which were diagnosed as herpes zoster and post-herpetic neuralgia. The patient was prescribed "Idomethacin", oxycodone, gabapentin and hydrocodone for management of her painful symptoms and pain. As a direct and proximate result of the ZOSTAVAX vaccine, and or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The reporter considered the events to be related to ZOSTAVAX. The outcome of the events was unknown. Additional information has been requested.
Weakness; not feeling well; Shingles outbreak; rash on back/ rash that looks like; This case was reported by a other health professional via call center representative and described the occurrence of shingles in a 87-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   In June 2019, the patient received the 1st dose of Shingrix. In June 2019, 5 days after receiving Shingrix, the patient experienced shingles and varicella-like rash. On 15th June 2019, the patient experienced weakness and feeling unwell. The patient was treated with valaciclovir hydrochloride (Valtrex). On an unknown date, the outcome of the shingles, varicella-like rash, weakness and feeling unwell were unknown.   It was unknown if the reporter considered the shingles, varicella-like rash, weakness and feeling unwell to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported, but it could be 86 or 87 years. The patient got 1st dose Shingrix and the patient was feeling weak and not feeling well.   On 20th June 2019, the patient experienced rash that looks like shingles on his back. The physician diagnosed patient with shingles and prescribed Valtrex. The reporter did not consent to follow-up.
Patient potentially received higher than the recommended 0.3ml dose of the Pfizer vaccine. As of Sunday 4/4, patient reports body aches and headache only slight worse than after receiving the 1st dose.
Pt reported that same day she received Pneumovax she had chills, fever and generalized body aches and her right arm felt swollen. She stated she was in bed for 1 1/2 days following her shot. She noted no bruises or redness.
Tingling of tongue & roof of mouth b/P 160/80 pulse60    10:36 b/p 160/94 pulse 68 11:05 tingling gone denies other signs or symptoms     Informed to call 911 if difficulty swallowing or breathing.  Seek medical attention if symptoms get worse
Fatigue, dizziness, feet, hand numbness, double vision, weakness, pain in legs, arms, face numbness. Transverse myelitis.
Shot was given at 10:15 at on 3/16. That night around 1:40 am my son suffered a fever above 101. He started having spasms and collapsed to the floor. He started convulsing uncontrollably for over 5 minutes ( had a seizure) head to toe convulsing and turning pale. EMS was called and he was taken to ER. They gave Tylenol and monitored for a few hours. Continued alternating Tylenol and motrin for 5 days until the fever broke. Contacted pediatrician and met in person regarding the sever adverse reaction and was given a medical exemption. He is going to follow up with an allergist and neurologist due to this reaction.
Patient called on 10/29/2019 at 4pm to report of an adverse event. Patient went to the emergency room on 10/27/2019 at nighttime. Patient reported of severe erythema. Patient also reported that she is fine now.
16 hrs p/inject had t102, stomach feeling funny, diarrhea, chills, no appetite, temp fluctuated over entire time; seconday day had dizziness, diarrhea; sx lasted 3 days;
I had pain at the injection site, swollen, body aches, and headache.  It eventually just went away on its own.  Did not take anything for it.  Arm feels better after using it.  Now I am just tired.
This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EP6955) via an unspecified route of administration in the left arm on 24Mar2021 at 07:30 (at the age of 50-years-old) as a single dose for COVID -19 immunization. Medical history and concomitant medications were not reported. The patient had a history of allergy to nuts and narcotics. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6199) via an unspecified route of administration in the left arm on 03Mar2021 at 07:15 (at the age of 50-years-old) as a single dose for COVID-19 immunization. The patient did not receive any other vaccine within 4 weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 25Mar2021 at 13:00 (second day), the patient experienced swollen underarm lymph nodes and rash in legs and arms. No therapeutic measures were taken as a result of the events. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of swollen lymph nodes and rash in legs and arms was resolving at the time of this report.   No follow-up attempts are needed. No further information is expected.
Patient reporting tenderness when moving arm. Patient reports 0/10 at rest. 5/10 if raised above head. Patient states he feels weaker in that arm since the injection. Patient assessed in office and refused any imagining or treatment. Provider believes a nerve is affected/irritated after injection. there is no redness, no mass, no other symptoms besides pain and weakness, only in the affected arm. Patient contacted us to let us know.
One week after receiving the Covid vaccine I developed some itching,  The injection site is red and inflamed.
Pt c/o feeling the room spin, lightheadedness, diaphoretic. Nsg Assess - A/O x 4, speech clear, skin warm, pk, slightly flushed. Lungs clear bilateral, heart tones tachy - S1S2, BP 160/72, HR 96. Pt sitting with feet elevated. Cool washcloth to forehead. Left arm site without signs of local reaction. Daughter called to room to calm pt. Pt sat for 30 min - BP decreased to 120/82, HR 86, reg. No resp distress, skim W/D.
When she gave me the vaccination it really hurt. I thought maybe she poked me wrong. The lower part of my arm in the elbow had a sharp pain. I had to take off a month of work. The doctor prescribed me amitriptyline. The pain moved to my shoulder and chest.
0.25ml dose of the Moderna Bivalent vaccine was administered instead of 0.5ml dose.
Information has been received from a physician concerning an 8 week old female who on 9/8/06 was vaccinated with a 2ml oral dose of Rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human Bovine) (lot 655153/0847F). Concomitant vaccine administered on the same day included a dose of Prevnar, a dose of Dtap, poliovirus vaccine and a dose of Hib/Hep B vaccine. It was reported, that, over the weekend of 9/9/06 to 9/10/06, the pt developed an extensive case of hives on her face, arms, legs, and abdomen and went to the ER. No product quality complaint was involved. Additional information has been requested.
pt recvd vax;apap given;T 102.6;arms/legs jerking x 1 min;lips blue,not breathing;pupils small & fixed;mom gave 2 breaths then pt resumed breathing;to MD in er;8mar dx:ear/throat infect,bronchitis;on bactrim,apap & motrin;
Low grade fever, muscle aches in lower back and legs, fatigue experienced less than 24 hours after time of vaccination, worsening throughout the day. Marked improvement by 30 hours post-injection - only arm soreness and lack of mobility in arm experienced at that time. Recovered fully approximately 72-96 hours later.
Muscle soreness, fatigue, low grade fever of 100.4, swelling 6 inches below injection site.  Then over the next several days developed pin-prick rash on both feet and ankles (petechiae?), general redness on lower legs.  Residual amount still remains 3 weeks later.
I experienced intense tingling in my feet after three days which moved up from my groin to my arms. I kept getting this internal vibration sensation that would not go away, dizziness and vertigo, tinnitus, blood pressure and pulse elevation, and panic attacks that came out of nowhere. I called my doctor and was prescribed Medrol dose pack which helped the internal vibrations and when I lowered the dose it did not help at all (first two months it remained unchanged and then it faded away). I still have the internal vibration in my legs along with tingling that is still happening today. The internal vibrating are intermittent, dizziness is just about gone and the tinnitus is still there along with migraines that I continue to experience. I went to the ER and they ran some tests on me because of my panic attack. I went to a Neurologist and he ordered an MRI.
Woke up with sore left arm, weak and had chills. Passed out in the bathroom at 9 pm 2/13/21, hit head and injured shoulder. Did not feel faint-like prior tp passing out.
Vaccine administered 3/19/2021 @ 1:45 pm. Notices redness in face and neck at 3:45 pm, Notices rash on face,neck, upper chest, arms, back, stomach, and hips at 9:30 pm. Contacted on call doctor at 10:05 pm. Treatment plan implemented at 10:15 pm of 50 mg benadryl every 6 hrs for 24 hrs and 20 mg pepcid 2 x day for 24 hours. Monitor through night for respiratory or other side effects.  Outcome to be determined.
Information has been received from a lawyer regarding a case in litigation concerning a female patient (age unknown). The patient's medical history, concurrent conditions and concomitant medication use were not provided. On or about 09-NOV-2012 the patient was vaccinated with ZOSTAVAX, (lot# and route unknown) as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. On or about 28-DEC-2014 the patient was treated by a Physician Assistant for the onset of a severe vesicular rash accompanied by weakened immune symptoms, which was diagnosed as herpes zoster or shingles. The patient has been prescribed famciclovir (FAMVIR) for management of her painful symptoms. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. Additional information has been requested.
pneumonia; This spontaneous case was reported by a consumer and describes the occurrence of PNEUMONIA (pneumonia) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 004M20A and 011L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PNEUMONIA (pneumonia) (seriousness criterion medically significant). At the time of the report, PNEUMONIA (pneumonia) outcome was unknown.            No concomitant product information were provided by the reporter. Patient went into the need for surgery on the pleura 2 months ago. No treatment information was provided by the reporter.  Company comment: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
MILD HEART ATTACK; BLOOD PRESSURE THROUGH THE ROOF; DIED; BLOOD CLOTS(BLOOD WAS LIKE GEL); 2 STROKES; SEIZURES; AMPUTATED LEG; This spontaneous report received from a consumer via media concerned a female of unspecified age, race and ethnicity. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin, and batch number and expiry date were not reported) dose was not reported, 1 total administered on MAR-2021 for covid-19 prophylaxis. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On unspecified date in MAR-2021 first night after vaccination, patient ended up in hospital with a mild heart attack, two days later blood pressure was through the roof. The number of days of hospitalization was not reported. Laboratory data included: Blood pressure (Blood pressure through the roof). On unspecified date in 2021, the patient experienced blood clots (Blood was like gel), 2 strokes, seizures, and amputated leg.  On unspecified date in DEC-2021, the patient died from unknown cause of death. It was unspecified if an autopsy was performed. The reporter stated, "my step mother had the J&J jab March 2021 and had immediate reaction. Ended up in hospital first night with a mild heart attack, two days later BP through the roof. Blood clots, 2 strokes, amputated leg, seizures and died on Dec 2021. Blood was like gel." The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient died on DEC-2021, and the outcome of blood clots (Blood was like gel), 2 strokes, mild heart attack, blood pressure through the roof, amputated leg and seizures was not reported. This report was serious (Death, Hospitalization Caused / Prolonged, and Other Medically Important Condition).; Sender's Comments: V0: 20230306847-Died, amputated leg. Insufficient information is available to make a causality assessment. Therefore, this event is considered unclassifiable. 20230306847- mild heart attack, Blood pressure through the roof. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable. 20230306847- 2 strokes, seizures. The event has an unknown/unclear temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable. 20230306847- blood clots (Blood was like gel). The event has an unknown/unclear temporal relationship, is unlabeled, and is scientifically plausible. There is no information on any other factors potentially associated with the event. Therefore, the WHO Causality is considered indeterminate. The company causality is considered unassessable.; Reported Cause(s) of Death: UNKNOWN CAUSE OF DEATH
Patient complained about feeling lightheaded about 15 minutes after receiving vaccination around 10:00 AM. I walked the patient back to her chair, before we arrived, patient fainted onto the floor, I caught her and laid her down on the floor. We elevated her feet thirty degrees, took vitals and called a code blue. Patient was ANO X3 by the time the code blue team arrived.